What predicts the change from episodic to chronic migraine?

Marcelo E. Bigal, Richard B. Lipton

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

While we wait for evidence regarding the benefits of risk factor modifications in the prevention of chronic migraine, several interventions are justifiable based on their other established benefits. For example, decreasing headache frequency with behavioral and pharmacological interventions will decrease current disability even if it does not modify clinical course. Monitoring the body mass index and encouraging maintenance of normal body weight is good practice in patients with and without migraine. Avoiding overuse of caffeine is desirable apart from its potential benefit in preventing progression. Sleep problems should be investigated and treated. Psychiatric comorbidities should be identified and addressed. Medications containing opioids and barbiturates should be reserved for a few selected cases of migraine, and their use should be monitored. For these interventions, the possibility of preventing progression may motivate clinicians to offer good care and patients to engage in the treatment plan.

Original languageEnglish (US)
Pages (from-to)269-276
Number of pages8
JournalCurrent Opinion in Neurology
Volume22
Issue number3
DOIs
StatePublished - Jun 2009

Fingerprint

Migraine Disorders
Ideal Body Weight
Barbiturates
Caffeine
Opioid Analgesics
Headache
Psychiatry
Comorbidity
Patient Care
Sleep
Body Mass Index
Maintenance
Pharmacology
Therapeutics

Keywords

  • Chronic migraine
  • Risk factors
  • Transformed migraine

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

What predicts the change from episodic to chronic migraine? / Bigal, Marcelo E.; Lipton, Richard B.

In: Current Opinion in Neurology, Vol. 22, No. 3, 06.2009, p. 269-276.

Research output: Contribution to journalArticle

@article{4ea9ab945860434692e7fe6ba7e9a377,
title = "What predicts the change from episodic to chronic migraine?",
abstract = "While we wait for evidence regarding the benefits of risk factor modifications in the prevention of chronic migraine, several interventions are justifiable based on their other established benefits. For example, decreasing headache frequency with behavioral and pharmacological interventions will decrease current disability even if it does not modify clinical course. Monitoring the body mass index and encouraging maintenance of normal body weight is good practice in patients with and without migraine. Avoiding overuse of caffeine is desirable apart from its potential benefit in preventing progression. Sleep problems should be investigated and treated. Psychiatric comorbidities should be identified and addressed. Medications containing opioids and barbiturates should be reserved for a few selected cases of migraine, and their use should be monitored. For these interventions, the possibility of preventing progression may motivate clinicians to offer good care and patients to engage in the treatment plan.",
keywords = "Chronic migraine, Risk factors, Transformed migraine",
author = "Bigal, {Marcelo E.} and Lipton, {Richard B.}",
year = "2009",
month = "6",
doi = "10.1097/WCO.0b013e32832b2387",
language = "English (US)",
volume = "22",
pages = "269--276",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - What predicts the change from episodic to chronic migraine?

AU - Bigal, Marcelo E.

AU - Lipton, Richard B.

PY - 2009/6

Y1 - 2009/6

N2 - While we wait for evidence regarding the benefits of risk factor modifications in the prevention of chronic migraine, several interventions are justifiable based on their other established benefits. For example, decreasing headache frequency with behavioral and pharmacological interventions will decrease current disability even if it does not modify clinical course. Monitoring the body mass index and encouraging maintenance of normal body weight is good practice in patients with and without migraine. Avoiding overuse of caffeine is desirable apart from its potential benefit in preventing progression. Sleep problems should be investigated and treated. Psychiatric comorbidities should be identified and addressed. Medications containing opioids and barbiturates should be reserved for a few selected cases of migraine, and their use should be monitored. For these interventions, the possibility of preventing progression may motivate clinicians to offer good care and patients to engage in the treatment plan.

AB - While we wait for evidence regarding the benefits of risk factor modifications in the prevention of chronic migraine, several interventions are justifiable based on their other established benefits. For example, decreasing headache frequency with behavioral and pharmacological interventions will decrease current disability even if it does not modify clinical course. Monitoring the body mass index and encouraging maintenance of normal body weight is good practice in patients with and without migraine. Avoiding overuse of caffeine is desirable apart from its potential benefit in preventing progression. Sleep problems should be investigated and treated. Psychiatric comorbidities should be identified and addressed. Medications containing opioids and barbiturates should be reserved for a few selected cases of migraine, and their use should be monitored. For these interventions, the possibility of preventing progression may motivate clinicians to offer good care and patients to engage in the treatment plan.

KW - Chronic migraine

KW - Risk factors

KW - Transformed migraine

UR - http://www.scopus.com/inward/record.url?scp=67049108840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049108840&partnerID=8YFLogxK

U2 - 10.1097/WCO.0b013e32832b2387

DO - 10.1097/WCO.0b013e32832b2387

M3 - Article

C2 - 19381087

AN - SCOPUS:67049108840

VL - 22

SP - 269

EP - 276

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 3

ER -